Synbionik is Drug Discovery in Germany that focus on matching bioreactor systems business. Founded in 2019. They cover business area such as provider, genetically modify microorganism, match bioreactor system, chemical compound, cannabinoid, cannabidiol, CBD, cannabigerol, (CBG, tetrahydrocannabinol, this biosynthetic approach, drastic cost, purity and sustainability advantage, traditional production or extraction method, biotech engineer, cannabis-base device, medicine.
2019
( 5 years old in 2024 )
Matching Bioreactor Systems
-
Weismüllerstraße 50
60314 Frankfurt
Germany
Private
providergenetically modify microorganismmatch bioreactor systemchemical compoundcannabinoidcannabidiolCBDcannabigerol(CBGtetrahydrocannabinolthis biosynthetic approachdrastic cost, purity and sustainability advantagetraditional production or extraction methodbiotech engineercannabis-base devicemedicine
* We use standard office opening hours in near Synbionik's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Synbionik is Drug Discovery business from Germany that founded in 2019 (5 years old in 2024), Synbionik business is focusing on Matching Bioreactor Systems.
Synbionik headquarter office and corporate office address is located in Weismüllerstraße 50 60314 Frankfurt Germany.
Synbionik was founded in Germany.
In 2024, Synbionik is currently focus on matching bioreactor systems sector.
Above is snippet of Google Trends for "matching bioreactor systems" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Synbionik, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
